Report: Anabiya and Broadcom are examining production on the Intel chip

Intel stated last week that the development process of this chip was over, and it was now learned that a number of manufacturers were investigating it – however, the result of this test was not given. Broadcom previously examined the same chip in his early stage, but concluded that he was not ripe.

Sensitive timing to Intel

The announcement of the testing process is published in Reuters in sensitive timing for Intel: The chip company has argued that it has finished developing the new production process, which will allow it to skip non-advanced 10 and 7-nm remedy to less than 2 nm and compete with the competitive TSMC production processes. However, she announced that the start of the production of these chips was postponed for 2026 and is now published in Reuters that an additional six months will be rejected in the readiness of the production tracks for the new tenology. At the same time, the company rejected the opening of the new factory it builds in Ohio from 2028 to 2030, when it should start full production only at 2032.

The start of 1.8-nm chipset production is critical to Intel survival as a leading company, as success in this test will allow it to compete with TSMC, which is already producing a 2 and 3-nm guitaria for Anbia, Marvel, Broadcom, Apple, Qualcomm and Amazon. Intel wants to bite TSMC dominance in the market and advanced chip development is the key to it. On the other hand, the chip companies are asking for 1.8 nm technology in Intel is stable enough for mass production. Such an achievement will allow Intel to survive or at least be sold in a nice return. However, failure in the development of the chip may defraud the kidney company.